Table 4: Multivariate analysis of overall survival for C-HCC and NC-HCC patients.
Variables |
Multivariate Analysis |
||||||
C-HCC |
NC-HCC |
||||||
P value |
HR |
95%Cl |
P value |
HR |
95% Cl |
||
BMI |
- |
- |
- |
0.048 |
0.905 |
.791-0.953 |
|
Surveillance : Yes vs. No |
0.64 |
1.265 |
0.907-1.764 |
- |
- |
- |
|
Extrahepatic metastasis: Yes vs. No |
0.71 |
1.108 |
0.644-1.36 |
- |
- |
- |
|
Portal vein invasion: Yes vs. No |
0.056 |
0.621 |
0.383-1.019 |
- |
- |
- |
|
BCLC stage |
|
<0.001 |
|
|
0.374 |
|
|
0 |
0.056 |
0.357 |
0.082-0.121 |
NA |
NA |
NA |
|
A |
0.159 |
0.322 |
0.162-0.628 |
0.697 |
1.545 |
0.499-4.789 |
|
B |
0.952 |
1.026 |
0.439-2.410 |
0.510 |
0.833 |
.294-2.362 |
|
C |
0.039 |
2.100 |
1.038-4.248 |
|
|
|
|
Treatment |
|
<0.001 |
|
|
0.013 |
|
|
Transplant |
<0.001 |
0.042 |
0.163-0.113 |
0.046 |
0.109 |
0.012-0.961 |
|
Resection |
<0.001 |
0.125 |
0.042-0.613 |
0.002 |
0.044 |
0.021-0220 |
|
RFA/MWA |
<0.001 |
0.260 |
0.301-0.403 |
0.972 |
0.001 |
0.027-1.101 |
|
Loco-regional |
<0.001 |
0.194 |
0.093-0.473 |
0.097 |
0.165 |
0.02-1.382 |
|
Systemic |
<0.001 |
0.249 |
0.131-0.901 |
0.079 |
0.213 |
0.038-0.642 |
C-HCC: Cirrhotic Hepatocellular Carcinoma group; NC-HCC: Non-Cirrhotic Hepatocellular Carcinoma group; BMI: Body mass index (cm /kg2); BCLC: Barcelona Clinic Liver Cancer; 95% Cl: Interval de Confidenta; NA: Not Applicable.